BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

817 related articles for article (PubMed ID: 15277277)

  • 1. Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma.
    Chang JT; Katzka DA
    Arch Intern Med; 2004 Jul; 164(14):1482-8. PubMed ID: 15277277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for Barrett's esophagus.
    Spechler SJ
    Rev Gastroenterol Disord; 2002; 2 Suppl 2():S25-9. PubMed ID: 12478241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does screening for Barrett's esophagus and adenocarcinoma of the esophagus prolong survival?
    Dellon ES; Shaheen NJ
    J Clin Oncol; 2005 Jul; 23(20):4478-82. PubMed ID: 16002837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Barrett's esophagus: cases and questions.
    Bresalier R
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S2-5. PubMed ID: 16399421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastroesophageal reflux and adenocarcinoma of the esophagus.
    Heath EI; Holbrook JT; Forastiere AA
    N Engl J Med; 1999 Aug; 341(7):536-7; author reply 537-8. PubMed ID: 10447438
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk factors, DNA damage, and disease progression in Barrett's esophagus.
    Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of esophageal adenocarcinoma.
    Pera M; Manterola C; Vidal O; Grande L
    J Surg Oncol; 2005 Dec; 92(3):151-9. PubMed ID: 16299786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia.
    Anandasabapathy S; Jhamb J; Davila M; Wei C; Morris J; Bresalier R
    Cancer; 2007 Feb; 109(4):668-74. PubMed ID: 17211862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and molecular biology of Barrett esophagus.
    Casson AG; Williams L; Guernsey DL
    Semin Thorac Cardiovasc Surg; 2005; 17(4):284-91. PubMed ID: 16428034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esophagitis: incidence and risk of esophageal adenocarcinoma--a population-based cohort study.
    Lassen A; Hallas J; de Muckadell OB
    Am J Gastroenterol; 2006 Jun; 101(6):1193-9. PubMed ID: 16771936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial Barrett esophagus and adenocarcinoma of the gastroesophageal junction.
    Eng C; Spechler SJ; Ruben R; Li FP
    Cancer Epidemiol Biomarkers Prev; 1993; 2(4):397-9. PubMed ID: 8348064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D1 polymorphism (G870A) and risk for esophageal adenocarcinoma.
    Casson AG; Zheng Z; Evans SC; Geldenhuys L; van Zanten SV; Veugelers PJ; Porter GA; Guernsey DL
    Cancer; 2005 Aug; 104(4):730-9. PubMed ID: 15971196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review.
    Shaheen N; Ransohoff DF
    JAMA; 2002 Apr; 287(15):1972-81. PubMed ID: 11960540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barrett's esophagus in patients with gastroesophageal reflux disease. Medical therapy or antireflux surgery?
    Klaus A; Mühlmann G; Kirchmayr W; Weiss H; Wetscher GJ
    Minerva Chir; 2002 Aug; 57(4):397-402. PubMed ID: 12145570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.
    Lagergren J; Bergström R; Lindgren A; Nyrén O
    N Engl J Med; 1999 Mar; 340(11):825-31. PubMed ID: 10080844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for esophageal cancer development.
    Falk GW
    Surg Oncol Clin N Am; 2009 Jul; 18(3):469-85. PubMed ID: 19500737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Any role for endoscopy screening or surveillance for esophageal adenocarcinoma among persons with GERD?
    Lagergren J
    Gastrointest Endosc; 2008 Nov; 68(5):856-8. PubMed ID: 18984099
    [No Abstract]   [Full Text] [Related]  

  • 18. High risk of malignancy in familial Barrett's esophagus: presentation of one family.
    Munitiz V; Parrilla P; Ortiz A; Martinez-de-Haro LF; Yelamos J; Molina J
    J Clin Gastroenterol; 2008 Aug; 42(7):806-9. PubMed ID: 18385604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familiality in Barrett's esophagus, adenocarcinoma of the esophagus, and adenocarcinoma of the gastroesophageal junction.
    Chak A; Ochs-Balcom H; Falk G; Grady WM; Kinnard M; Willis JE; Elston R; Eng C
    Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1668-73. PubMed ID: 16985029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gastroesophageal reflux disease and malignancy].
    Richert Z; Robaszkiewicz M
    Rev Prat; 2008 Sep; 58(13):1414-5, 1417, 1419-20. PubMed ID: 18924321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.